Other Name(s): BRCA
Drug Target Analysis Report Drug Target Analysis Report Content

About the Target

Based on the provided context information, several key viewpoints can be extracted regarding BRCA1:

BRCA1 haploinsufficiency leads to chromatin looping deficiency and impaired transcriptional activation [1].
BRCA1 is essential for mitophagy and its deficiency can result in the accumulation of damaged mitochondria and inflammation, contributing to tumorigenesis and cancer metastasis [2].
Long non-coding RNAs (lncRNAs) play a role in regulating the radioresistance of BRCA, potentially through mechanisms such as DNA repair, apoptosis, autophagy, cell cycle regulation, and others [3].
Mutated BRCA1 can lead to elevated R-loops at enhancer and/or promoter regions of luminal fate genes, downregulating their expression and potentially contributing to the formation of basal-like BRCA1-associated tumors [4].
BRCA1 is involved in subnetworks of genes mutated in ovarian carcinomas, including TP53, MYC, and CTNNB1, despite not being differentially expressed itself [5].

These viewpoints provide insights into the various roles and mechanisms involving BRCA1, such as its contribution to chromatin looping, mitophagy, radioresistance regulation, breast differentiation, and its relevance in ovarian carcinomas.
Based on the provided context information, several key viewpoints can be extracted regarding the role of BRCA1:

In wild-type cells, the MRE11 and EXO1 branch may be less prevalent compared to the DNA2/WRN branch, with an inhibitory feedback from WRN to MRE11 possibly contributing to this arrangement [6]. However, in BRCA1 or BRCA2-defective cells, the MRE11 and EXO1 branch dominates, and WRN is no longer a contributor. This results in DNA breakage and increased DNA damage due to fork collapse and segregation of under-replicated DNA [6].

BRCA1 is involved in the regulation of DNA repair choice and interacts with UHRF1 to form a cascade that influences this process [7].

Depletion of BRCA1 leads to an increase in colocalized markers of defective replication, such as pATRThr1989 and pChk1S345, with TERRA RNA at telomeres. This suggests that BRCA1 is important for suppressing replication-associated telomeric damage and maintaining telomere integrity [8].

BRCA1 plays a role in suppressing and resolving R-loops at subtelomeric and telomeric regions, thereby modulating their heterochromatic state and preventing replication stress. Excessive TERRA levels and unresolved R-loops lead to replication stress, telomeric aberrancies, and telomere shortening [8].

Shieldin, which includes BRCA1 as a component, functions by binding to single-stranded DNA at double-strand break (DSB) sites and suppressing resection. This promotes non-homologous end joining (NHEJ) for DSB repair [9].

In the Fanconi anemia (FA) pathway of interstrand crosslink (ICL) repair, BRCA1 acts to dismantle the replisome and promotes the recruitment of nucleases for nucleolytic incisions. This facilitates lesion bypass and subsequent repair through homologous recombination (HR) [10].

These viewpoints provide a comprehensive summary of the various roles and functions of BRCA1 in DNA repair, replication, and telomere integrity.

Figure [1]

Figure [2]

Figure [3]

Figure [4]

Figure [5]

Figure [6]

Figure [7]

Figure [8]

Figure [9]

Figure [10]

Note: If you are interested in the full version of this target analysis report, or if you'd like to learn how our AI-powered BDE-Chem can design therapeutic molecules to interact with the BRCA1 target at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai.

More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BECN1 | BRAF | BRCA1 | CAMP | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CD8A | CDH1 | CDKN1A | CDKN2A | CREB1 | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | EREG | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA4 | HSPA5 | IDO1 | IFNA1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MDM2 | MET | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SLTM | SMAD4 | SOD1 | SQSTM1 | SRC | STAT1 | STAT3 | STAT5A | TAK1 | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1